Surging global incidence of age-related macular degeneration, expanding diabetic retinopathy patient populations, and continuous biopharmaceutical refinements in anti-VEGF fusion proteins are driving rapid growth across the global Aflibercept Drug Market. Aflibercept active pharmaceutical ingredients and finished biopharmaceutical dosage forms—comprising intravitreal pre-filled syringes,...
